American College of Clinical Pharmacy
      Search      Cart
         
ACCP Report

ACCP Research Institute Receives Record In-Kind Donation from Cerner

ACCP Research Institute

The Research Institute (RI) announces the receipt of a truly significant in-kind donation from the Cerner Corporation. “In recognition of the efforts of the ACCP Research Institute to advance pharmacotherapy in the treatment and prevention of disease, Cerner has partnered with the Research Institute by providing use of its Discovere research platform to facilitate research conducted by ACCP members,” explains Kent Wessely, Sr. Engagement Leader, Life Sciences at Cerner.

Cerner, a global leader in health care information technology, has headquarters in the Kansas City metropolitan area, like ACCP. “With the start-up of the new ACCP PBRN, we needed a robust and secure IT infrastructure,” states the RI’s Director, Jacqueline Marinac. “It seemed logical to begin conversations with companies that may have a vested interest in local businesses and yet share our mission and values.” Indeed, Cerner and the RI share common ground. In Mr. Wessely’s words, “Together, Cerner and the ACCP Research Institute are making a difference.”

The Cerner Discovere platform, the single largest in-kind donation received by the RI to date, “facilitates the integration of research into the health care workflow through an intuitive, easy-to-use interface,” notes Wessely. Moreover, by determining the role-based rights and privileges specific to each protocol, the Discovere system will allow the ACCP PBRN to be fully compliant with the FDA’s 21 CFR Part 11 rule on electronic signatures and records. The ACCP PBRN, which will host the system on its own servers and have sole rights and ownership of all data collected, will be capable of managing numerous concurrent trials of varying sizes and complexity as well as track accrual metrics and study milestones across all protocols or at the protocol/patient level.

According to Grace Kuo, ACCP PBRN Director, the Cerner Discovere system will enhance the ACCP PBRN’s ability to conduct translational research projects effectively and efficiently in numerous ways, providing a central data repository where patient data can be securely electronically stored, monitored, and analyzed; increasing the PBRN’s efficiency in data collection, data entry, and data retrieval tasks; and preparing the PBRN to compete for federally funded projects/programs. The President, the Congress, and many federal funding agencies have all identified EMR/HIT (electronic medical record/health information technology) as a priority clinical tool. The Discovere platform will also allow the ACCP PBRN more competitiveness with other PBRNs in obtaining funding.

Recently, the ACCP PBRN installed Cerner’s Discovere study platform as its Web-based data collection and study management tool. Cerner, which will provide in-house training for PBRN staff, program updates, and technical support to the RI, is “grateful for the opportunity to assist ACCP,” says Cerner Sr. Vice President, Research, Douglas S. McNair, M.D., Ph.D. “The crucial concept of ‘return value’ or ROI is important to commercial companies and to nonprofits as well. Every gesture of giving tends to create value.” Moreover, he states, “In an era when health care draws angry shouts from the disenchanted and misinformed, so much depends on creating knowledge and a spirit of community toward the public good. Thank you again for collaborating with us!”